Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLONAZEPAM vs CLOTIAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLONAZEPAM vs CLOTIAZEPAM: Safety Overview

Metric CLONAZEPAM CLOTIAZEPAM
Total FAERS Reports 39,463 323
Deaths Reported 8,488 41
Death Rate 21.5% 12.7%
Hospitalizations 12,506 207
Average Patient Age 46.0 yrs 50.5 yrs
% Female Patients 58.3% 59.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Advagen Pharma Ltd N/A
Route ORAL N/A
Marketing Status Prescription N/A